CClinicalTrials.gg
CompletedNCT02066090Updated Nov 17, 2017

Acupuncture for Obesity on Serum Metabolic Parameters

An interventional study of Real acupuncture and Sham acupuncture in Obesity, sponsored by Kyung Hee University Hospital at Gangdong. Completed at 1 site in Korea, Republic of. Open to female participants aged 19 Years to 55 Years. Per ClinicalTrials.gov, last updated 2017-11-17.

Sponsored by Kyung Hee University Hospital at Gangdong · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
19 Years to 55 Years
Sex
Female
01

Study summary

This research is planned to build a basis about the effect of acupuncture on serum metabolic parameters in pre-menopausal obese women with economic evaluation.

Read the detailed description

It is consisted with two sub research.

First, clinical research to assess the effect of acupuncture for obesity on serum metabolic parameters will be processed with randomized, patient-assessor blinding, and sham-acupuncture controlled study design. 120 subjects would be collected and divided into two groups(experimental and placebo, 60 subjects each). Experimental group will undergo with real acupuncture treatment(manual acupuncture + electroacupuncture) twice a week, for 6 weeks. The effect on serum metabolic parameters will be assessed at 0 and 6 weeks.

Second is qualitative research to make a basis through the evaluation of economic efficacy and patients' satisfaction with acupuncture treatment for obesity.

02

Conditions studied

  • Obesity

Browse trials for

Keywords

  • acupuncture
  • obesity
  • metabolomics
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

This study's enrollment of 120 is above the median of 78 across 4,878 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Kyung Hee University Hospital at Gangdong is the lead sponsor of 22 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 55 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • volunteers through announcements and advertisements
  • premenopausal adult women (19 years of age or more)
  • clinical diagnosis of obesity (Body mass index: 25 kg/m2 or more)

Exclusion criteria

Exclusion Criteria:

  • previously or currently having endocrine disease such as hypothyroidism or Cushing's syndrome, heart disease, lung disease, diabetes, malignant tumor, cholelithiasis, severe kidney impairment, severe liver impairment, anorexia nervosa or hyperorexia
  • experience of taking medicines which might affect body weight and the concentration of serum metabolic parameters such as anorectic, laxative, oral steroid, thyroid hormone, amphetamine, cyproheptadine, phenothiazine, or medicines affecting absorption, metabolism, and excretion in the past 3 months
  • experience of taking beta-blocker or diuretic for the treatment of hypertension in the past 3 months
  • surgical treatment for the treatment of obesity
  • currently or might be pregnant or breast-feeding
  • experience of taking other experimental medicines in the past month
  • weight loss of 10% or more of previous body weight in the past 6 months
  • who stopped smoking in the past 3 months or who have irregular smoking habit
  • pacemaker
  • currently receiving any treatment for obesity
  • other inadequate subjects assessed by the study investigators
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    Real acupuncture

    manual acupuncture + electroacupuncture, twice a week, for 6 weeks

    Device: Real acupuncture

  • Sham comparator
    Sham acupuncture

    sham acupuncture + placebo acupuncture without electrical stimulation, twice a week, for 6 weeks

    Device: Sham acupuncture

Interventions

  • DeviceReal acupuncture

    manual acupuncture (bilateral LI4, LI11, SP6, ST25, ST28, ST36) + electroacupuncture (middle CV6, CV12), twice a week, for 6 weeks common approaches for the treatment of obesity used by doctors of Korean medicine in Korea today

  • DeviceSham acupuncture

    sham acupuncture (bilateral LI4, LI11, SP6, ST25, ST28, ST36) + placebo acupuncture without electrical stimulation (middle CV6, CV12), twice a week, for 6 weeks sham acupuncture (0.25mm diameter x 40mm length, stainless steel, Acuprime, UK) as control for manual acupuncture (0.25mm diameter x 40mm length, stainless steel, Dongbangacupuncture Inc., Korea) placebo acupuncture without electrical stimulation as control for electroacupuncture (0.25mm diameter x 90mm length, stainless steel, Dongbangacupuncture Inc., Korea)

06

What researchers measure

Primary outcomes

  1. change in serum metabolic profile

    Time frame: before treatment at week1 (baseline) and after treatment at week6 (endpoint)

Secondary outcomes

  1. change in body weight

    using bioelectrical impedance analysis (BIA)

    Time frame: baseline, 1, 2, 3, 4, 5, and 6 weeks

  2. change in body fat mass

    using bioelectrical impedance analysis (BIA)

    Time frame: baseline, 1, 2, 3, 4, 5, and 6 weeks

  3. change in muscle mass

    using bioelectrical impedance analysis (BIA)

    Time frame: baseline, 1, 2, 3, 4, 5, and 6 weeks

  4. change in waist circumference

    Time frame: baseline, 1, 2, 3, 4, 5, and 6 weeks

  5. change in hip circumference

    Time frame: baseline, 1, 2, 3, 4, 5, and 6 weeks

  6. change in Beck Depression Index (BDI)

    Time frame: baseline and 6 weeks

  7. change in Social Readjustment Rating Scale (SRRS)

    Time frame: baseline and 6 weeks

  8. change in Stress Response Inventory (SRI)

    Time frame: baseline and 6 weeks

  9. change in International Physical Activity Questionnaire (IPAQ)

    Time frame: baseline and 6 weeks

  10. change in Fatigue Severity Scale (FSS)

    Time frame: baseline, 1, 2, 3, 4, 5, and 6 weeks

  11. heart rate variability (HRV)

    Time frame: just before treatment at visit1(baseline), 10 minutes after treatment at visit1, just before treatment at visit12 (6 weeks), 10 minutes after treatment at visit12(end point)

  12. number of participants with adverse events

    * assessment of severity: mild, moderate, severe * assessment of relation: definitely related, probably related, possibly related, probably not related, definitely not related, unknown

    Time frame: up to the end of study

Other outcomes

  1. change in Measure Yourself Medical Outcome Profile (MYMOP)

    outcome measure for the evaluation of patients' satisfaction and economic efficacy in secondary sub-study

    Time frame: baseline, 1, 2, 3, 4, 5, and 6 weeks

  2. change in EuroQol-5 Dimension (EQ-5D)

    outcome measure for the evaluation of patients' satisfaction and economic efficacy in secondary sub-study

    Time frame: baseline and 6 weeks

07

Study locations

1 site
  • Kyung Hee University Korean Medicine Hospital at Gangdong
    Seoul, 134-727, Korea, Republic of
08

References and documents

Publications

  • Kim KW, Shin WC, Choi MS, Cho JH, Park HJ, Yoo HH, Song MY. Effects of acupuncture on anthropometric and serum metabolic parameters in premenopausal overweight and obese women: a randomized, patient- and assessor-blind, sham-controlled clinical trial. Acupunct Med. 2021 Feb;39(1):30-40. doi: 10.1177/0964528420912259. Epub 2020 Apr 17. PubMed 32299241 ↗
  • Kim KW, Yoo HH, Cho JH, Yang YC, Kim JI, Kim SY, Park JY, Park HJ, Song MY. Effects of acupuncture on serum metabolic parameters in premenopausal obese women: study protocol for a randomized controlled trial. Trials. 2015 Aug 4;16:327. doi: 10.1186/s13063-015-0867-y. PubMed 26238111 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 17, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02066090
Lead sponsor
Kyung Hee University Hospital at Gangdong
Responsible party
Mi-Yeon Song (Professor, K.M.D., Ph.D., Kyung Hee University Hospital at Gangdong) — Principal investigator
First posted
Feb 19, 2014
Start date
Mar 2014
Primary completion
Feb 2016
Completion
Feb 2016
Last update
Nov 17, 2017

Study contacts

Mi-Yeon Song, Ph.D.
principal investigator · Department of Rehabilitation Medicine of Korean Medicine, Kyung Hee University Gangdong Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion